WallStSmart

Karooooo Ltd (KARO)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Karooooo Ltd generates 1928% more annual revenue ($5.25B vs $258.90M). KARO leads profitability with a 19.5% profit margin vs -15.5%. KARO earns a higher WallStSmart Score of 62/100 (C+).

KARO

Buy

62

out of 100

Grade: C+

Growth: 7.3Profit: 9.5Value: 7.0Quality: 7.0
Piotroski: 5/9Altman Z: 3.43

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KAROUndervalued (+87.3%)

Margin of Safety

+87.3%

Fair Value

$391.02

Current Price

$49.62

$341.40 discount

UndervaluedFair: $391.02Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KARO5 strengths · Avg: 9.0/10
Return on EquityProfitability
33.6%10/10

Every $100 of equity generates 34 in profit

Altman Z-ScoreHealth
3.4310/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.259/10

Conservative balance sheet, low leverage

Operating MarginProfitability
26.2%8/10

Strong operational efficiency at 26.2%

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KARO2 concerns · Avg: 2.5/10
Market CapQuality
$1.53B3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$02/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KARO

The strongest argument for KARO centers on Return on Equity, Altman Z-Score, Debt/Equity. Profitability is solid with margins at 19.5% and operating margin at 26.2%. Revenue growth of 21.6% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KARO

The primary concerns for KARO are Market Cap, Free Cash Flow.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KARO profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KARO scores higher overall (62/100 vs 41/100), backed by strong 19.5% margins and 21.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Karooooo Ltd

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Karooooo Ltd. develops a vehicle fleet management software solution. The company is headquartered in Singapore.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?